Welcome to our dedicated page for American Vanguard news (Ticker: AVD), a resource for investors and traders seeking the latest updates and insights on American Vanguard stock.
American Vanguard Corporation reports on its specialty agriculture and related product portfolio, including crop protection and management, turf and ornamentals management, public health, animal health and commercial pest control. The company develops, manufactures and markets synthetic, biological and biorational products, with a global registration base built through product and business acquisitions.
Recurring news for American Vanguard includes quarterly and annual earnings, product and margin commentary, manufacturing optimization, North American commercial execution, capital-structure actions and credit-facility updates. Company updates also discuss operating initiatives tied to working capital, debt reduction, manufacturing footprint and the organization of its crop and specialty businesses.
Cruiser Capital, a significant shareholder of American Vanguard (AVD), owning 2.5% of shares, criticized the company's Board for underperformance and governance issues. They claim AVD's stock price has declined over the past decade compared to peers. Cruiser urges shareholders to support their director nominees to implement necessary changes. AVD's recent financial disclosures raised concerns over transparency, including a reported $222 million in sales and a 15% EBITDA margin, leading to questions about the accuracy and context of these figures. They stress the need for independent oversight to enhance shareholder value.
American Vanguard Corporation (NYSE: AVD) has issued a letter to stockholders ahead of its Annual Meeting scheduled for June 1, 2022. The letter emphasizes the qualifications of the Company’s nine director nominees and urges stockholders to vote for them on the WHITE proxy card. The Board highlights its past performance, including outperformance of the Russell 2000 and consistent dividend payments, while countering claims made by Cruiser Capital regarding their nominees. American Vanguard asserts its nominees possess superior experience and capability to maintain the Company’s growth trajectory.
Cruiser Capital, a significant shareholder of American Vanguard Corporation (NYSE:AVD), holding 2.5% of shares, has called for major changes in the company's board. In a recent presentation, Cruiser highlighted a decade of underperformance and the need for improved corporate governance. They are urging stockholders to vote for Cruiser's three nominees at the upcoming Annual Meeting on June 1, 2022, to enhance operational efficiency and long-term shareholder value. Cruiser emphasizes that current board members exhibit an entrenched mindset detrimental to stakeholders.
American Vanguard Corporation (NYSE: AVD) reported strong Q1 2022 results, exceeding revenue and EBITDA targets, driven by strategic actions and technological innovations. Net sales increased from $116.2 million to $149.4 million, while net income rose from $3.1 million to $9.9 million, marking a 219.4% growth. The company anticipates mid-double-digit growth for the year. The board recommends stockholders vote for its nine experienced director nominees against Cruiser Capital, whose candidates lack a clear plan. The annual meeting is set for June 1, 2022.
American Vanguard Corporation (NYSE: AVD) reported a strong start to fiscal 2022, with net sales increasing by 29% to $149.4 million and net income surging 224% to $9.9 million for Q1 2022 compared to Q1 2021. Earnings per diluted share rose to $0.33. The EBITDA also improved significantly to $22.9 million. The company achieved a 41% gross profit margin while reducing operating expenses to 31% of sales. Growth was driven by increased demand for crop protection solutions and successful international expansions.
American Vanguard Corporation (NYSE: AVD) will report its financial results for Q1 ended March 31, 2022, on May 4, 2022, after market close. A conference call will follow at 4:30 PM ET, led by CEO Eric Wintemute, COO Bob Trogele, and CFO David T. Johnson. Investors can join by calling 862-298-0702 or via live webcast on the company’s website. American Vanguard specializes in agricultural products and is included in the Russell 2000 and S&P SmallCap 600 Indexes.
American Vanguard Corporation (NYSE:AVD) has filed its definitive proxy statement with the SEC for its 2022 Annual Meeting scheduled on June 1, 2022. The company urges stockholders to vote for its experienced board nominees using the WHITE proxy card and to disregard any materials from activist hedge fund Cruiser Capital Advisors LLC, which aims to replace three board members. American Vanguard highlights its strong performance with 21% sales growth in the previous year and anticipates mid-double-digit growth in 2022, supported by its SIMPAS platform and Green Solutions portfolio.
American Vanguard Corporation (NYSE: AVD) has filed a preliminary proxy statement with the SEC for its 2022 Annual Meeting on June 1, 2022. The record date for stockholders to vote is April 8, 2022. The company has nominated its nine existing directors for re-election and disclosed that Cruiser Capital intends to nominate four individuals for election to the board. American Vanguard emphasizes its commitment to long-term value creation and believes its nominated directors have significant industry expertise.
American Vanguard Corporation (NYSE: AVD) has declared a cash dividend of $0.025 per share, payable on April 15, 2022, to shareholders on record as of March 25, 2022. This decision reflects the Board's confidence in the company's financial stability and growth initiatives. For 2022, the total anticipated cash dividends amount to $0.045, compared to $0.080 in 2021. The 2022 Annual Shareholders Meeting is scheduled for June 1, 2022, at 11:00 am PT, to be held virtually.
American Vanguard Corporation (NYSE: AVD) reported strong financial results for FY 2021, showing a 21% increase in net sales to $557 million compared to $459 million in FY 2020. Operating income rose 35% to $30.9 million, while net income increased to $18.6 million, translating to earnings per diluted share of $0.61. The company faced challenges like COVID-19 and supply chain disruptions but managed to maintain profit margins through price increases. A share repurchase program for up to one million shares was also announced, reflecting confidence in long-term success.